Inventor
LIN XIANFENG
CN15 patents
⚠️ This page may combine multiple inventors who share the name “LIN XIANFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
11 patentsUS9447086B2Sep 20, 2016
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE34 citations93
US9233978B2Jan 12, 2016
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE18 citations91
US10428069B2Oct 1, 2019
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE6 citations83
US10081627B2Sep 25, 2018
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE9 citations83
US9758530B2Sep 12, 2017
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE3 citations71
US9266904B2Feb 23, 2016
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE5 citations71
US12351575B2Jul 8, 2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations61
US10683299B2Jun 16, 2020
Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases
HOFFMANN LA ROCHE0 citations41
US9856247B2Jan 2, 2018
4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection
HOFFMANN LA ROCHE0 citations39
US10662203B2May 26, 2020
Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
HOFFMANN LA ROCHE0 citations38
US10597380B2Mar 24, 2020
Pyridazinone-based broad spectrum anti-influenza inhibitors
HOFFMANN LA ROCHE0 citations38